Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Puri Raj K.
Iovance Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH
Iovance Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Puri Raj K.
Iovance Biotherapeutics | 8-K: Current report
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Maynard Ryan D
Iovance Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(8.8%),Joseph Edelman(8.8%), etc.
Iovance Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Iovance Biotherapeutics | 8-K: Current report
Iovance Biotherapeutics | 10-Q: Q3 2024 Earnings Report
Iovance Biotherapeutics | 8-K: Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
Iovance Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.4%)
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR
No Data